UC Davis researchers raceed to develop coronavirus solutions
On Mar. 20, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
Edmonton company Entos Pharma developing DNA vaccine against COVID-19
On Mar. 18, 2020, Entos Pharmaceuticals announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections….
Emergent Biosolutions signed development and manufacturing agreement with Vaxart for experimental Coronavirus oral vaccine
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced it has released the first batch of mRNA-1273, the Companyï¾’s vaccine against…
CureVac focuses on development of mRNA-based coronavirus vaccine to protect people worldwide
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
Fosun Pharma and BioNTech formed COVID-19 vaccine strategic alliance in China
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
CureVac’s optimized mRNA platform provided positive pre-clinical results at low dose for Coronavirus vaccine candidate
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
Johnson & Johnson collaborated with Beth Israel Deaconess Medical Center to accelerate COVID-19 vaccine development
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
CaroGen and Yale scientists joined to develop a COVID-19 vaccine
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
Heat Biologics collaborated with University of Miami to develop COVID-19 Coronavirus vaccine
On Mar. 5, 2020, Heat Biologics announced a strategic collaboration with the University of Miami Miller School of…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
Heat Biologics launched program to develop vaccine to protect against COVID-19 coronavirus
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
CDC | COVID-19 | Diagnostics | Life Science News | NIH | Therapeutics | Vaccine
COVID-19 a reminder of the challenge of emerging infectious diseases
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
Altimmune Completed First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
Tonix Pharma announced collaboration with Southern Research to develop vaccine to protect against COVID-19 based on Horsepox virus
On Feb. 26, 2020, Tonix Pharmaceuticals announced a strategic collaboration with Southern Research to support the development of…
Clover and GSK announced research collaboration to evaluate Coronavirus vaccine candidate with pandemic adjuvant system
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…
Texas Biomed established team to study SARS-CoV-2, new coronavirus
On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…
FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
The CPRIT awarded 55 new grants totaling over $78 million
On Feb. 19, 2020, Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55 grants…
Sanofi joined with US Dept of Health and Human Services to advance novel coronavirus vaccine
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…